Researcher Profile

Researcher Profile

Jonathan Stine, MD, MSc

Jonathan Stine, MD, MSc

Assistant Professor, Department of Medicine
Division of Gastroenterology and Hepatology
Assistant Professor, Department of Public Health Sciences
Scientific Program:Cancer Control
jgs178@psu.edu
View Website

Research Interests

Dr. Jonathan Stine's clinical and research areas of expertise include NAFLD, coagulation disorders in chronic liver disease, drug-induced liver injury (DILI) and liver transplantation.

The majority of his early work focused on DILI in both the population at large, as well as in special populations, including the elderly and patients with underlying chronic liver disease including cirrhosis.

His more recent work has focused on liver transplantation coagulation disorders and outcomes-based research in which the link between pre- and post-transplantation vascular events was demonstrated.

Additionally, Dr. Stine and his research group found that despite broader organ-sharing policies, geographic disparities persist and regional access to liver transplantation remains highly variable and inequitable.

Dr. Stine is the principal investigator on the NASHFit Trial and is continuing forward his work on the hypercoagulable environment in NASH patients, where he previously demonstrated that NASH increases one's risk of venous thromboembolic disease.

Dr. Stine serves as the Director of Research for Penn State Liver Center.

  • Liver
  • Thrombosis
  • Fibrosis
  • Portal Vein
  • Chemical and Drug Induced Liver Injury
  • Transplants
  • Therapeutics
  • Liver Transplantation
  • Non-alcoholic Fatty Liver Disease
  • Pharmaceutical Preparations
  • Liver Diseases
  • Mortality

Recent Publications

2020

Mellinger, JL & Stine, JG 2020, 'Early Liver Transplantation for Severe Alcoholic Hepatitis', Digestive Diseases and Sciences, vol. 65, no. 6, pp. 1608-1614. https://doi.org/10.1007/s10620-020-06159-9
Spinosa, M & Stine, JG 2020, 'Nonalcoholic fatty liver disease-evidence for a thrombophilic state?', Current Pharmaceutical Design, vol. 26, no. 10, pp. 1036-1044. https://doi.org/10.2174/1381612826666200131101553
Stine, JG, Schreibman, I, Navabi, S, Kang, M, Dahmus, J, Soriano, C, Rivas, G, Hummer, B, Beyer, M, Tressler, H, Kimball, SR, Patterson, AD, Schmitz, K & Sciamanna, C 2020, 'Nonalcoholic steatohepatitis Fitness Intervention in Thrombosis (NASHFit): Study protocol for a randomized controlled trial of a supervised aerobic exercise program to reduce elevated clotting risk in patients with NASH', Contemporary Clinical Trials Communications, vol. 18, 100560. https://doi.org/10.1016/j.conctc.2020.100560

2019

Stine, JG, Intagliata, NM, Shah, NL, Lisman, T, Violi, F, Caldwell, SH & Argo, CK 2020, 'Clinical Cirrhosis Dilemmas: Survey of Practice from the 7th International Coagulation in Liver Disease Conference', Digestive Diseases and Sciences, vol. 65, no. 5, pp. 1334-1339. https://doi.org/10.1007/s10620-019-05884-0
Stine, J 2019, 'Concise Commentary: The Clot Thickens—Why Pylephlebitis Is One of the Most Feared Complications of Intra-abdominal Sepsis', Digestive Diseases and Sciences, vol. 64, no. 6, pp. 1722-1723. https://doi.org/10.1007/s10620-018-5440-6
Gaballa, D, Bezinover, D, Kadry, Z, Eyster, E, Wang, M, Northup, PG & Stine, JG 2019, 'Development of a Model to Predict Portal Vein Thrombosis in Liver Transplant Candidates: The Portal Vein Thrombosis Risk Index', Liver Transplantation, vol. 25, no. 12, pp. 1747-1755. https://doi.org/10.1002/lt.25630
Bezinover, D, Navabi, S, Wang, M, Li, Z, William, M & Stine, JG 2019, 'Hyponatremia Is Protective Against the Development of Portal Vein Thrombosis in Patients Undergoing Liver Transplant', Transplantation proceedings, vol. 51, no. 6, pp. 1880-1886. https://doi.org/10.1016/j.transproceed.2019.05.014
Stine, JG 2020, 'I’m a Junior Faculty Member at an Academic Medical Center…Now What?', Digestive Diseases and Sciences, vol. 65, no. 1, pp. 15-17. https://doi.org/10.1007/s10620-019-05946-3
Stine, JG, Stukenborg, GJ, Wang, J, Adkins, A, Niccum, B, Zimmet, A & Argo, CK 2020, 'Liver transplant candidates have impaired quality of life across health domains as assessed by computerized testing', Annals of Hepatology, vol. 19, no. 1, pp. 62-68. https://doi.org/10.1016/j.aohep.2019.06.018
Shenoy, A, Stine, JG & Intagliata, NM 2019, 'Venous thromboembolism in patients with liver diseases: comment', Journal of Thrombosis and Haemostasis, vol. 17, no. 1, pp. 238-239. https://doi.org/10.1111/jth.14320

2018

Intagliata, NM, Argo, CK, Stine, JG, Lisman, T, Caldwell, SH & Violi, F 2018, 'Concepts and Controversies in Haemostasis and Thrombosis Associated with Liver Disease: Proceedings of the 7th International Coagulation in Liver Disease Conference', Thrombosis and Haemostasis, vol. 118, no. 8, pp. 1491-1506. https://doi.org/10.1055/s-0038-1666861
Stine, JG, Bezinover, D & Kadry, Z 2018, 'Coronary artery disease in decompensated patients undergoing liver transplantation evaluation', Liver Transplantation, vol. 24, no. 7, pp. 976-977. https://doi.org/10.1002/lt.25064
Stine, JG, Wang, J, Shah, PM, Argo, CK, Intagliata, N, Uflacker, A, Caldwell, SH & Northup, PG 2018, 'Decreased portal vein velocity is predictive of the development of portal vein thrombosis: A matched case-control study', Liver International, vol. 38, no. 1, pp. 94-101. https://doi.org/10.1111/liv.13500
Stine, JG, Northup, PG, Stukenborg, GJ, Cornella, SL, Maluf, DG, Pelletier, SJ & Argo, CK 2018, 'Geographic variation in liver transplantation persists despite implementation of Share35', Hepatology Research, vol. 48, no. 4, pp. 225-232. https://doi.org/10.1111/hepr.12922
Verbeek, TA, Stine, JG, Saner, FH & Bezinover, D 2018, 'Hypercoagulability in end-stage liver disease: Review of epidemiology, etiology, and management', Transplantation Direct, vol. 4, no. 11, e401. https://doi.org/10.1097/TXD.0000000000000843
Stine, JG, Niccum, BA, Zimmet, AN, Intagliata, N, Caldwell, SH, Argo, CK & Northup, PG 2018, 'Increased risk of venous thromboembolism in hospitalized patients with cirrhosis due to non-alcoholic steatohepatitis original-contribution', Clinical and Translational Gastroenterology, vol. 9, no. 3, 140. https://doi.org/10.1038/s41424-018-0002-y
Stine, J & Northup, PG 2019, 'Management of Non-tumoral Portal Vein Thrombosis in Patients with Cirrhosis', Digestive Diseases and Sciences, vol. 64, no. 3, pp. 619-626. https://doi.org/10.1007/s10620-018-5427-3
Bezinover, D, Deacutis, MF, Dalal, P, Moore, RP, Stine, J, Wang, M, Reeder, E, Hollenbeak, CS, Saner, FH, Riley III, T & Janicki, P 2019, 'Perioperative thrombotic complications associated with pediatric liver transplantation: a UNOS database evaluation', HPB, vol. 21, no. 3, pp. 370-378. https://doi.org/10.1016/j.hpb.2018.08.014
Argo, CK, Stine, J, Henry, ZH, Lackner, C, Patrie, JT, Weltman, AL & Caldwell, SH 2018, 'Physical deconditioning is the common denominator in both obese and overweight subjects with nonalcoholic steatohepatitis', Alimentary Pharmacology and Therapeutics, vol. 48, no. 3, pp. 290-299. https://doi.org/10.1111/apt.14803
Stine, JG, Prakash, S & Northup, PG 2018, 'Portal vein thrombosis after hepatitis C eradication with direct acting antiviral therapy', Liver International, vol. 38, no. 1, pp. 185-186. https://doi.org/10.1111/liv.13537
Stine, JG, Wentworth, BJ, Zimmet, A, Rinella, ME, Loomba, R, Caldwell, SH & Argo, CK 2018, 'Systematic review with meta-analysis: risk of hepatocellular carcinoma in non-alcoholic steatohepatitis without cirrhosis compared to other liver diseases', Alimentary Pharmacology and Therapeutics, vol. 48, no. 7, pp. 696-703. https://doi.org/10.1111/apt.14937
Stine, JG, Wang, J, Cornella, SL, Behm, BW, Henry, Z, Shah, NL, Caldwell, SH & Northup, PG 2018, 'Treatment of type-1 hepatorenal syndrome with pentoxifylline: A randomized placebo controlled clinical trial', Annals of Hepatology, vol. 17, no. 2, pp. 300-306. https://doi.org/10.5604/01.3001.0010.8660

2017

Stine, JG, Argo, CK, Pelletier, SJ, Maluf, DG, Caldwell, SH & Northup, PG 2017, 'Advanced non-alcoholic steatohepatitis cirrhosis: A high-risk population for pre-liver transplant portal vein thrombosis', World Journal of Hepatology, vol. 9, no. 3, pp. 139-146. https://doi.org/10.4254/wjh.v9.i3.139
Stine, JG & Northup, PG 2017, 'Coagulopathy Before and After Liver Transplantation: From the Hepatic to the Systemic Circulatory Systems', Clinics in Liver Disease, vol. 21, no. 2, pp. 253-274. https://doi.org/10.1016/j.cld.2016.12.003
Stine, JG & Chalasani, NP 2017, 'Drug Hepatotoxicity: Environmental Factors', Clinics in Liver Disease, vol. 21, no. 1, pp. 103-113. https://doi.org/10.1016/j.cld.2016.08.008
Stine, JG & Rinella, ME 2017, 'Editorial: Age and Non-Invasive Markers of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease: Time to Adjust the Clock?', American Journal of Gastroenterology, vol. 112, no. 5, pp. 752-754. https://doi.org/10.1038/ajg.2017.60
Stine, JG, Wynter, JA, Niccum, B, Kelly, V, Caldwell, SH & Shah, NL 2017, 'Effect of treatment with direct acting antiviral on glycemic control in patients with diabetes mellitus and chronic hepatitis C', Annals of Hepatology, vol. 16, no. 2, pp. 215-220. https://doi.org/10.5604/16652681.1231579
Stine, JG, Intagliata, N, Northup, PG & Caldwell, SH 2017, 'Nonalcoholic Fatty Liver Disease, Portal Vein Thrombosis and Coagulation: More Questions Than Answers?', Transplantation, vol. 101, no. 8, pp. e281-e282. https://doi.org/10.1097/TP.0000000000001807
Stine, JG, Wynter, JA, Niccum, B, Kelly, V, Caldwell, SH & Shah, NL 2017, 'Reply to “HbA1c levels as a parameter of glycemic control in patients with liver cirrhosis”', Annals of Hepatology, vol. 16, no. 3, pp. 471-472. https://doi.org/10.5604/16652681.1235497
Myc, LA, Stine, JG, Chakrapani, R, Kadl, A & Argo, CK 2017, 'Vasopressin use in critically ill cirrhosis patients with catecholamine-resistant septic shock: The CVICU cohort', World Journal of Hepatology, vol. 9, no. 2, pp. 106-113. https://doi.org/10.4254/wjh.v9.i2.106

2016

Stine, JG & Northup, PG 2016, 'Autoimmune-like drug-induced liver injury: a review and update for the clinician', Expert Opinion on Drug Metabolism and Toxicology, vol. 12, no. 11, pp. 1291-1301. https://doi.org/10.1080/17425255.2016.1211110
Stine, J, Wang, J & Behm, BW 2016, 'Chronic Cholestatic Liver Injury Attributable to Vedolizumab', Journal of Clinical and Translational Hepatology, vol. 4, no. 3, pp. 277-280.
Wynter, J, Stine, JG & Shah, NL 2016, 'Chronic hepatitis C and diabetes: More questions than answers with the new direct acting antiviral drugs?', Digestive and Liver Disease, vol. 48, no. 9. https://doi.org/10.1016/j.dld.2016.05.007
Stine, JG & Lewis, JH 2016, 'Current and future directions in the treatment and prevention of drug-induced liver injury: A systematic review', Expert Review of Gastroenterology and Hepatology, vol. 10, no. 4, pp. 517-536. https://doi.org/10.1586/17474124.2016.1127756
Stine, J & Caldwell, SH 2016, 'Hepatology highlights', Annals of Hepatology, vol. 15, no. 4, pp. 460-462.
Stine, JG, Argo, CK, Pelletier, SJ, Maluf, DG & Northup, PG 2016, 'Liver transplant recipients with portal vein thrombosis receiving an organ from a high-risk donor are at an increased risk for graft loss due to hepatic artery thrombosis', Transplant International, vol. 29, no. 12, pp. 1286-1295. https://doi.org/10.1111/tri.12855
Stine, JG, Pelletier, SJ, Schmitt, TM, Porte, RJ & Northup, PG 2016, 'Pre-transplant portal vein thrombosis is an independent risk factor for graft loss due to hepatic artery thrombosis in liver transplant recipients', HPB, vol. 18, no. 3, pp. 279-286. https://doi.org/10.1016/j.hpb.2015.10.008

Clinical Trials Search


Children (age < 18 years)
Adults (age >= 18 years)